Search
for
Sort by
Research 571–600 of 1000+
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Nutraceutical : An emerging Pharmaceutical Towards Prevention Of Diseases
- Editorial Comment
- Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
- Finasteride en de preventie van prostaatcarcinoom
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- PCSK9: From Nature’s Loss to Patient’s Gain
- Reply
- Imaging tumor angiogenesis with fluorescent proteins
- Novel inhibitors of 5α-reductase
- Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product
- The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
- Insulin Resistance Syndrome- the Sensitive IRS
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Editorial Comment
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Sulfatase inhibitors: a patent review
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Cellular senescence in tissue repair: every cloud has a silver lining
- Novedades terapéuticas en tricología
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Current treatment of BPH
- Wwox Deficiency Causes Downregulation of Prosurvival ERK Signaling and Abnormal Homeostatic Responses in Mouse Skin
- Finasteride associated melasma in a Caucasian male.
- Organic and Biogenic Nanocarriers as Bio-Friendly Systems for Bioactive Compounds’ Delivery: State-of-the Art and Challenges
- Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method